Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03054506 · ClinicalTrials.gov registry record · NA
The Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT03054506: Completed NA study, sponsored by Massachusetts General Hospital.
NCT03054506 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 52 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03054506, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
Constipation is a common gastrointestinal motility disorder that is often chronic, negatively affects patients' daily lives. Constipation occurs when bowel movements become difficult or less frequent.This study is being done to study the effectiveness of the hydrogel capsule, CSP01, compared to the active control (carboxymethylcellulose) and placebo (non-medicine sugar pill), to relieve constipation among subjects with chronic idiopathic constipation (CIC) or with irritable bowel syndrome with constipation (IBS-C).
Interventions
- DEVICE Placebo
- DEVICE CSP01
- DEVICE Carboxymethylcellulose (CMC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2017-03-07 |
| Est. Completion | 2019-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03054506
The ClinicalTrials.gov registry entry for NCT03054506 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03054506 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03054506 about?
NCT03054506 is a clinical study titled "The Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation". Constipation is a common gastrointestinal motility disorder that is often chronic, negatively affects patients' daily lives. Constipation occurs when bowel movements become difficult or less frequent.This study is being done to study the effectiveness of the hydrogel capsule, CSP01, compared to the ...
What is the current status of trial NCT03054506?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2017-03-07. Estimated completion is 2019-02-01.
What interventions are being tested in trial NCT03054506?
The interventions under investigation include: Placebo (DEVICE), CSP01 (DEVICE), Carboxymethylcellulose (CMC) (DEVICE).
Who is sponsoring clinical trial NCT03054506?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.